Vivek Kumar Singh
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications 3
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 4
- Acute Myeloid Leukemia Research 2
-
- Epigenetics and DNA Methylation 2
- RNA Interference and Gene Delivery 2
-
- Click Chemistry and Applications 2
- Synthesis and biological activity 2
-
- Tuberculosis Research and Epidemiology 2
- Co-authors
- Mohane Selvaraj CoumarIndira GhoshHsing‐Pang HsiehAkhil C. BanerjeaP. SankarLarance RonsardKumaravel MohankumarRukkumani Rajagopalan
- Partner nations
- IndiaTaiwanUnited States
In The Last Decade
Vivek Kumar Singh
20 papers receiving 486 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 47
- Hematology 76
- Toxicology 16
- Molecular Biology 304
- Cancer Research 64
Countries citing papers authored by Vivek Kumar Singh
This map shows the geographic impact of Vivek Kumar Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Kumar Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Kumar Singh more than expected).
Fields of papers citing papers by Vivek Kumar Singh
This network shows the impact of papers produced by Vivek Kumar Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Kumar Singh. The network helps show where Vivek Kumar Singh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vivek Kumar Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2022 | 4 | |
| 3 | Regulatory noncoding RNAs: potential biomarkers and therapeutic targets in acute myeloid leukemia. | 2021 | 11 |
| 4 | 2021 | 4 | |
| 5 | 2019 | 68 | |
| 6 | 2018 | 17 | |
| 7 | 2017 | 6 | |
| 8 | 2017 | 14 | |
| 9 | 2017 | 9 | |
| 10 | 2017 | 4 | |
| 11 | 2016 | 23 | |
| 12 | 2015 | 64 | |
| 13 | 2015 | 31 | |
| 14 | 2014 | 37 | |
| 15 | 2014 | 38 | |
| 16 | 2014 | 29 | |
| 17 | 2013 | 15 | |
| 18 | 2013 | 52 | |
| 19 | 2012 | 10 | |
| 20 | 2006 | 46 |
About Vivek Kumar Singh
Vivek Kumar Singh is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Hematology, having authored 20 papers that have together received 489 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), Curcumin's Biomedical Applications (3 papers), Acute Myeloid Leukemia Research (2 papers), Click Chemistry and Applications (2 papers), Synthesis and biological activity (2 papers), Tuberculosis Research and Epidemiology (2 papers), Epigenetics and DNA Methylation (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Molecular Medicine (47 citations), Hematology (76 citations) and Toxicology (16 citations). Vivek Kumar Singh has collaborated with scholars based in India, Taiwan and United States. Frequent co-authors include Mohane Selvaraj Coumar, Indira Ghosh, Hsing‐Pang Hsieh, Akhil C. Banerjea, P. Sankar, Larance Ronsard, Kumaravel Mohankumar, Rukkumani Rajagopalan, Yi-Yu Ke and Wen‐Hsing Lin. Their work appears in journals such as PLoS ONE, Scientific Reports and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.